Suppliers / Towa Pharmaceutical Europe, S.L

Towa Pharmaceutical Europe, S.L

Spain Updated 9 July 2026

Towa Pharmaceutical Europe, S.L is a finished-dose manufacturer based in Spain. It appears in 2,146 regulatory filings across 12 regulators, without an active US DMF or CEP on file. Its filings concentrate with AIFA (IT), INFARMED (PT) and AEMPS (ES). Its GMP standing is certified by EMA and AEMPS (ES). Its most recent recorded inspection, by US FDA, closed on 9 September 2022 as VAI.

active US DMFs

valid CEPs

registered plants 1 with an FDA FEI number

2,146

filings across 12 regulators

These figures were checked against the regulators' own files on 25 July 2026

Plants

1 of 1 confirmed

Inspections

6 of 6 confirmed

EU GMP

1 of 1 confirmed

Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

9 September 2022 VAI US FDA
18 January 2019 NAI US FDA
31 March 2017 VAI US FDA
13 February 2015 VAI US FDA
10 May 2013 NAI US FDA
19 February 2010 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site	FDA FEI
Barcelona, Spain	Not on file
Martorelles, Spain	Not on file
Spain, Spain	3003121577
Montjo, Portugal	Not on file
Montijo, Portugal	Not on file

Filings and GMP by regulator

Regulator	Filings	GMP certificates
AIFA (IT)	1,033	None
INFARMED (PT)	443	None
AEMPS (ES)	351	1
EMA	290	1
MPA (SE)	9	None
ARCSA (EC)	6	None

Comparing suppliers?

Choose your molecules and target markets. Towa Pharmaceutical Europe, S.L comes back tiered against every other supplier able to file there.

Start for free

No sales call.

Open risk flags

The most recent inspection outcome was VAI, on 9 September 2022.

Sources on this page

FDA: Drug master files, establishment registration, inspection classifications
EDQM: Certificates of suitability
EudraGMDP and national regulators: GMP certificates